ResMed holds recent Real Value of $84.63225 per share. The prevailing price of the company is $107.03. At this time the company appears to be over valued. Macroaxis determines value of ResMed from analyzing the company fundamentals such as Shares Outstanding of 142.74M, Operating Margin of
28.09% and Return On Equity of 15.29% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
Valuation Drivers Correlation
|Time Horizon||30 Days Login to change|